In the iAmBd group, there were 34.6% (9/26) cases with creatinine elevation, 23.1% (6/26) with hypokalemia, 19.2% (5/26) with ALT elevation, 11.5% (3/26) with infusion-related reactions, 7.7% (2/26) with anemia and 3.8% (1/26) with gastrointestinal reactions. This evidence concerns the gene GPT and anemia.